Francis Chou
Chou Associates Management
Francis Chou Teva Pharma Industries Ltd ADR stake
total: 81
Chou Associates Management TEVA trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2017 Q1
- Held for:
- 11 quarters
- Latest activity:
- 2019 Q4
According to 2026 Q2 report, Francis Chou doesn't hold any Teva Pharma Industries Ltd ADR (TEVA) shares. To date, the estimated cost basis is nearly $32.81 for "buy" trades and estimated average "sell" price is $18.58. Chou Associates Management first purchased TEVA in 2017 Q1, initially acquiring 215,000 shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA), Chou Associates Management has made 3 more transactions.
When did Francis Chou sell Teva Pharma Industries Ltd ADR (TEVA)?
Francis Chou sold off the entire Teva Pharma Industries Ltd ADR (TEVA) position in 2019 Q4.
When did Francis Chou buy Teva Pharma Industries Ltd ADR (TEVA)?
Francis Chou first invested in Teva Pharma Industries Ltd ADR (TEVA) in 2017 Q1 at the reported quarter-end price of $32.09 per share.
What's the cost basis of Chou Associates Management's TEVA stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA) stake is around $32.81 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $32.81
- Weighted AVG sell price:
- $18.58
Francis Chou's historical trades in Teva Pharma Industries Ltd ADR
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$6.87
|
-100% (-15,000)
|
|||
|
2017 Q4
|
0.12%
|
$18.93
|
-97.03% (-490,000)
|
|||
|
2017 Q2
|
5.20%
|
$33.34
|
+134.88% (+290,000)
|
|||
|
2017 Q1
|
2.29%
|
$32.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.